Stockholders' Equity - Schedule of Activity Related to Stock Option Plans (Details) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Shares  Available for Grant
Shares available for grant, beginning balances (in shares)	16,454,103	20,145,360	21,702,085
Options outstanding, number of shares, beginning balance (in shares)	19,896,861	17,595,851	18,676,810
Options outstanding, number of shares granted (in shares)	1,729,218	3,691,257	1,556,725
Options outstanding, number of shares, exercised (in shares)	(1,926,598)	(1,383,669)	(2,632,324)
Options outstanding, number of shares expired (in shares)	(4,372)	(6,578)	(5,360)
Shares available for grant, ending balances (in shares)	14,724,885	16,454,103	20,145,360
Options outstanding, number of shares, ending balance (in shares)	19,695,109	19,896,861	17,595,851
Options outstanding, number of shares, vested and expected to vest (in shares)	19,695,109
Options outstanding, number of shares, exercisable (in shares)	19,447,739
Weighted- Average Exercise Price (per share)
Options outstanding, weighted-average exercise price, beginning balance (in USD per share)	$ 242.22	$ 219.83	$ 170.23
Options outstanding, weighted-average exercise price, granted (in USD per share)	372.49	267.94	554.11
Options outstanding, weighted-average exercise price, exercised (in USD per share)	87.30	27.19	65.97
Options expired, weighted-average exercise price (in USD per share)	36.39	11.10	34.63
Options outstanding, weighted-average exercise price, ending balance (in USD per share)	268.86	$ 242.22	$ 219.83
Options outstanding, weighted-average exercise price, vested and expected to vest (in USD per share)	268.86
Options outstanding, weighted-average exercise price, vested and exercisable (in USD per share)	$ 267.37
Weighted- Average Remaining Contractual Term (in years)
Weighted-average remaining contractual term (in years)	5 years 4 months 6 days
Weighted-average exercise price, vested and exercisable, vested and expected to vest	5 years 4 months 6 days
Weighted-average remaining contractual term, exercisable	5 years 3 months 18 days
Aggregate Intrinsic Value (in thousands)
Aggregate intrinsic value	$ 4,429,404
Aggregate intrinsic value, vested and expected to vest	4,429,404
Aggregate intrinsic value, exercisable	$ 4,404,586